George Pentheroudakis
University of Ioannina
H-index: 67
Europe-Greece
Top articles of George Pentheroudakis
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer | ESMO open | PM Carrera G Curigliano D Santini L Sharp RJ Chan | 2024/5/1 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer | ESMO open | S-A Im A Gennari YH Park JH Kim Z-F Jiang | 2023/6/1 |
Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey | Annals of oncology: official journal of the European Society for Medical Oncology | P Comoli G Pentheroudakis A Ruggeri Ulrike Köhl F Lordick | 2024/4 |
Oncology phase I trial design and conduct: time for a change-MDICT Guidelines 2022 | D Araujo A Greystoke S Bates A Bayle E Calvo | 2023/1/1 | |
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit | Annals of Oncology | SF Oosting Jorge Barriuso A Bottomley M Galotti B Gyawali | 2023/4/1 |
ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC) | Annals of Oncology | S Loibl HA Azim Jr T Bachelot P Berveiller A Bosch | 2023/10/1 |
Artificial intelligence for predictive biomarker discovery in immuno-oncology: A systematic review | A Prelaj V Miskovic M Zanitti F Trovo C Genova | 2023/10/23 | |
Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ | Annals of Oncology | A Krämer T Bochtler C Pauli G Baciarello S Delorme | 2023/3/1 |
Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology—shared perspectives from international consortia | ESMO open | Luís Castelo-Branco Rebecca Lee Mariana Brandão Alessio Cortellini André Freitas | 2023/8/1 |
1689O Comprehensive mapping review of real-world evidence publications focusing on targeted therapies in solid tumors: A collaborative work from ESMO real-world data and … | A Pellat T Grinda A Prelaj P Cresta A Valachis | 2023/10/1 | |
Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines | G Zarkavelis AL Amylidi C Verbaanderd NI Cherny Y Metaxas | 2023/2/1 | |
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer | P Tarantino G Viale MF Press X Hu F Penault-Llorca | 2023/8/1 | |
1702P Real-world evidence contributions to European medicines agency’s safety and efficacy evaluations of oncology targeted therapies between 2018-2022 | Annals of Oncology | JWG Derksen D Martins Branco A Pellat SCMW Van Nassau A Valachis | 2023/10/1 |
European Lung Cancer Congress (ELCC) 2023 Officers | Journal of Thoracic Oncology | Martin Reck Noemi Reguart George Pentheroudakis Paul Van Schil Anne-Marie Baird | 2023 |
COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases | ESMO open | Pierre Martin Zoi Tsourti Joana Ribeiro Luis Castelo-Branco Evandro de Azambuja | 2023/6/1 |
2107P Thromboprophylaxis with intermediate or prophylactic doses of LMWHs in ambulatory cancer patients | Annals of Oncology | NG Tsoukalas AN Christopoulou E Timotheadou A Koumarianou A Ardavanis | 2023/10/1 |
Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials | Annals of Oncology | JL Perez-Gracia Nicolas Penel E Calvo A Awada HT Arkenau | 2023/1/1 |
Clinical Outcomes Beyond 1L EGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study ‘LUNGFUL’ | Anticancer Research | Giannis Mountzios Anna Koumarianou Helena Linardou Anastasios Boutis Dimitrios Mavroudis | 2023/5/1 |
Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain | ESMO open | F Roitberg T Amaral NI Cherny R Giuliani NJ Latino | 2023/10/1 |
ESMO guidance for reporting oncology real-world evidence (GROW) | ESMO Real World Data and Digital Oncology | L Castelo-Branco A Pellat D Martins-Branco Antonis Valachis JWG Derksen | 2023/11/1 |
